Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 10880

1.

Correction.

[No authors listed]

Br J Clin Pharmacol. 2018 Oct;84(10):2449. doi: 10.1111/bcp.13694. Epub 2018 Jul 20. No abstract available.

2.

Correction.

[No authors listed]

Br J Clin Pharmacol. 2018 Oct;84(10):2450. doi: 10.1111/bcp.13729. Epub 2018 Aug 15. No abstract available.

3.

Target site pharmacokinetics of doxycycline for rosacea in healthy volunteers is independent of the food effect.

Pal A, Matzneller P, Gautam A, Österreicher Z, Wulkersdorfer B, Reiter B, Stimpfl T, Zeitlinger M.

Br J Clin Pharmacol. 2018 Nov;84(11):2625-2633. doi: 10.1111/bcp.13721. Epub 2018 Aug 17.

4.

Correction.

[No authors listed]

Br J Clin Pharmacol. 2018 Aug;84(8):1860. doi: 10.1111/bcp.13644. Epub 2018 Jun 15. No abstract available.

5.

Pharmacokinetics, metabolism and safety of deuterated L-DOPA (SD-1077)/carbidopa compared to L-DOPA/carbidopa following single oral dose administration in healthy subjects.

Schneider F, Erisson L, Beygi H, Bradbury M, Cohen-Barak O, Grachev ID, Guzy S, Loupe PS, Levi M, McDonald M, Savola JM, Papapetropoulos S, Tracewell WG, Velinova M, Spiegelstein O.

Br J Clin Pharmacol. 2018 Oct;84(10):2422-2432. doi: 10.1111/bcp.13702. Epub 2018 Aug 9.

6.

Effect of single and multiple doses of elobixibat, an ileal bile acid transporter inhibitor, on chronic constipation: A randomized controlled trial.

Kumagai Y, Amano H, Sasaki Y, Nakagawa C, Maeda M, Oikawa I, Furuie H.

Br J Clin Pharmacol. 2018 Oct;84(10):2393-2404. doi: 10.1111/bcp.13698. Epub 2018 Aug 2.

7.

Relative bioavailability of bedaquiline tablets suspended in water: Implications for dosing in children.

Svensson EM, du Bois J, Kitshoff R, de Jager VR, Wiesner L, Norman J, Nachman S, Smith B, Diacon AH, Hesseling AC, Garcia-Prats AJ.

Br J Clin Pharmacol. 2018 Jun 27. doi: 10.1111/bcp.13696. [Epub ahead of print]

8.

Coadministration of probenecid and cimetidine with mirogabalin in healthy subjects: A phase 1, randomized, open-label, drug-drug interaction study.

Tachibana M, Yamamura N, Atiee GJ, Hsu C, Warren V, He L, Dishy V, Zahir H.

Br J Clin Pharmacol. 2018 Oct;84(10):2317-2324. doi: 10.1111/bcp.13674. Epub 2018 Aug 9.

9.

In vivo affinity and target engagement in skin and blood in a first-time-in-human study of an anti-oncostatin M monoclonal antibody.

Reid J, Zamuner S, Edwards K, Rumley SA, Nevin K, Feeney M, Zecchin C, Fernando D, Wisniacki N.

Br J Clin Pharmacol. 2018 Oct;84(10):2280-2291. doi: 10.1111/bcp.13669. Epub 2018 Jul 12.

10.

A systematic literature review of the human skin microbiome as biomarker for dermatological drug development.

Niemeyer-van der Kolk T, van der Wall HEC, Balmforth C, Van Doorn MBA, Rissmann R.

Br J Clin Pharmacol. 2018 Oct;84(10):2178-2193. doi: 10.1111/bcp.13662. Epub 2018 Jul 19. Review.

11.

Gastrointestinal bleeding risk of selective serotonin reuptake inhibitors by level of kidney function: A population-based cohort study.

Iwagami M, Tomlinson LA, Mansfield KE, Douglas IJ, Smeeth L, Nitsch D.

Br J Clin Pharmacol. 2018 Sep;84(9):2142-2151. doi: 10.1111/bcp.13660. Epub 2018 Jul 8.

12.

Desogestrel and panic attacks - a new suspected adverse drug reaction reported by patients and health care professionals on spontaneous reports.

Watson S, Härmark L.

Br J Clin Pharmacol. 2018 Aug;84(8):1858-1859. doi: 10.1111/bcp.13617. Epub 2018 May 24. No abstract available.

13.

Incidence and cost of medication harm in older adults following hospital discharge: a multicentre prospective study in the UK.

Parekh N, Ali K, Stevenson JM, Davies JG, Schiff R, Van der Cammen T, Harchowal J, Raftery J, Rajkumar C; PRIME study group.

Br J Clin Pharmacol. 2018 Aug;84(8):1789-1797. doi: 10.1111/bcp.13613. Epub 2018 May 31.

14.

Moderate correlation between systemic IL-6 responses and CRP with trough concentrations of voriconazole.

Vreugdenhil B, van der Velden WJFM, Feuth T, Kox M, Pickkers P, van de Veerdonk FL, Blijlevens NMA, Brüggemann RJM.

Br J Clin Pharmacol. 2018 Sep;84(9):1980-1988. doi: 10.1111/bcp.13627. Epub 2018 Jun 19.

15.

Futility of current urine salbutamol doping control.

Heuberger JAAC, van Dijkman SC, Cohen AF.

Br J Clin Pharmacol. 2018 Aug;84(8):1830-1838. doi: 10.1111/bcp.13619. Epub 2018 Jun 3.

16.

Physiologically-based pharmacokinetic model of vaginally administered dapivirine ring and film formulations.

Kay K, Shah DK, Rohan L, Bies R.

Br J Clin Pharmacol. 2018 Sep;84(9):1950-1969. doi: 10.1111/bcp.13625. Epub 2018 Jun 19.

17.

Cannabis, from plant to pill.

Grof CPL.

Br J Clin Pharmacol. 2018 Nov;84(11):2463-2467. doi: 10.1111/bcp.13618. Epub 2018 May 24. Review.

18.

Safe use of proton pump inhibitors in patients with cirrhosis.

Weersink RA, Bouma M, Burger DM, Drenth JPH, Harkes-Idzinga SF, Hunfeld NGM, Metselaar HJ, Monster-Simons MH, van Putten SAW, Taxis K, Borgsteede SD.

Br J Clin Pharmacol. 2018 Aug;84(8):1806-1820. doi: 10.1111/bcp.13615. Epub 2018 Jun 7.

19.

Optimization of a drug transporter probe cocktail: potential screening tool for transporter-mediated drug-drug interactions.

Stopfer P, Giessmann T, Hohl K, Hutzel S, Schmidt S, Gansser D, Ishiguro N, Taub ME, Sharma A, Ebner T, Müller F.

Br J Clin Pharmacol. 2018 Sep;84(9):1941-1949. doi: 10.1111/bcp.13609. Epub 2018 Jun 21.

20.

Large differences in neonatal drug use between NICUs are common practice: time for consensus?

Flint RB, van Beek F, Andriessen P, Zimmermann LJ, Liem KD, Reiss IKM, de Groot R, Tibboel D, Burger DM, Simons SHP; DINO Research group.

Br J Clin Pharmacol. 2018 Jun;84(6):1313-1323. doi: 10.1111/bcp.13563. Epub 2018 Apr 17.

Supplemental Content

Loading ...
Support Center